John Trizzino Insider Trading $NVAX NOVAVAX INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John Trizzino.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John Trizzino. John Trizzino is EVP, CBO and CFO in NOVAVAX INC ($NVAX) and EVP, CCO, CBO & Interim CFO in NOVAVAX INC ($NVAX) and EVP, Chief Commercial Officer in NOVAVAX INC ($NVAX) and EVP, CMO and CBO in NOVAVAX INC ($NVAX) and Snr. VP, Int & Govt Alliances in NOVAVAX INC ($NVAX) and SVP, CBO and CFO in NOVAVAX INC ($NVAX) and SVP, Commercial Operations in NOVAVAX INC ($NVAX).
John Trizzino in NOVAVAX INC
Trading Symbol: NVAXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of John Trizzino: EVP, CCO, CBO & Interim CFO, EVP, Chief Commercial Officer, EVP, CMO and CBO, EVP, CBO and CFO, SVP, CBO and CFO, SVP, Commercial Operations, Snr. VP, Int & Govt Alliances
Holdings: 704 shares
Current Value: $922
Latest Transaction: May 07 2021
$NVAX Market Capitalization: $355.26M
$NVAX Previous Close: $1.31
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John Trizzino in NOVAVAX INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Option Exercise | M | 5.95 | 384 | 2,285 | 11,117 | |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Option Exercise | M | 5.95 | 2,084 | 12,400 | 60,417 | |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Option Exercise | M | 46.00 | 521 | 23,966 | 10,423 | |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Option Exercise | M | 27.60 | 417 | 11,509 | 3,341 | |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Sell | S | 176.60 | 90 | 15,894 | 287 | 377 to 287 (-23.87 %) |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Sell | S | 176.65 | 100 | 17,665 | 377 | 477 to 377 (-20.96 %) |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Payment of Exercise | F | 171.74 | 180 | 30,913 | 477 | 657 to 477 (-27.40 %) |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Sell | D | 171.74 | 14 | 2,404 | 657 | 671 to 657 (-2.09 %) |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Buy | M | 5.95 | 384 | 2,285 | 671 | 287 to 671 (+133.80 %) |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Sell | S | 194.08 | 68 | 13,198 | 287 | 355 to 287 (-19.15 %) |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Sell | S | 192.81 | 246 | 47,431 | 355 | 601 to 355 (-40.93 %) |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Sell | S | 191.53 | 412 | 78,909 | 601 | 1 K to 601 (-40.67 %) |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Sell | S | 190.62 | 192 | 36,599 | 1,013 | 1.2 K to 1 K (-15.93 %) |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Sell | S | 189.46 | 364 | 68,962 | 1,205 | 1.6 K to 1.2 K (-23.20 %) |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Sell | S | 188.51 | 318 | 59,945 | 1,569 | 1.9 K to 1.6 K (-16.85 %) |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Sell | S | 187.36 | 186 | 34,848 | 1,887 | 2.1 K to 1.9 K (-8.97 %) |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Sell | S | 186.05 | 105 | 19,536 | 2,073 | 2.2 K to 2.1 K (-4.82 %) |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Sell | S | 184.25 | 252 | 46,430 | 2,178 | 2.4 K to 2.2 K (-10.37 %) |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Sell | S | 183.43 | 138 | 25,313 | 2,430 | 2.6 K to 2.4 K (-5.37 %) |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Sell | S | 182.45 | 160 | 29,192 | 2,568 | 2.7 K to 2.6 K (-5.87 %) |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Sell | S | 181.17 | 85 | 15,399 | 2,728 | 2.8 K to 2.7 K (-3.02 %) |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Sell | S | 180.37 | 70 | 12,626 | 2,813 | 2.9 K to 2.8 K (-2.43 %) |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Sell | S | 171.89 | 28 | 4,813 | 2,883 | 2.9 K to 2.9 K (-0.96 %) |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Sell | S | 171.09 | 208 | 35,586 | 2,911 | 3.1 K to 2.9 K (-6.67 %) |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Sell | S | 169.70 | 93 | 15,782 | 3,119 | 3.2 K to 3.1 K (-2.90 %) |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Sell | S | 168.34 | 13 | 2,188 | 3,212 | 3.2 K to 3.2 K (-0.40 %) |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Sell | S | 164.71 | 12 | 1,977 | 3,225 | 3.2 K to 3.2 K (-0.37 %) |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Sell | S | 163.03 | 72 | 11,738 | 3,237 | 3.3 K to 3.2 K (-2.18 %) |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Buy | M | 5.95 | 2,084 | 12,400 | 3,309 | 1.2 K to 3.3 K (+170.12 %) |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Buy | M | 46.00 | 521 | 23,966 | 1,225 | 704 to 1.2 K (+74.01 %) |
May 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CCO, CBO & Int ... | Buy | M | 27.60 | 417 | 11,509 | 704 | 287 to 704 (+145.30 %) |
Apr 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Option Exercise | M | 5.95 | 383 | 2,279 | 11,501 | |
Apr 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Option Exercise | M | 5.95 | 2,083 | 12,394 | 62,501 | |
Apr 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Option Exercise | M | 46.00 | 521 | 23,966 | 10,944 | |
Apr 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Option Exercise | M | 27.60 | 417 | 11,509 | 3,758 | |
Apr 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 178.03 | 191 | 34,004 | 287 | 478 to 287 (-39.96 %) |
Apr 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Payment of Exercise | F | 177.29 | 179 | 31,735 | 478 | 657 to 478 (-27.25 %) |
Apr 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | D | 177.29 | 13 | 2,305 | 657 | 670 to 657 (-1.94 %) |
Apr 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Buy | M | 177.29 | 383 | 67,902 | 670 | 287 to 670 (+133.45 %) |
Apr 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 190.10 | 3,021 | 574,292 | 287 | 3.3 K to 287 (-91.32 %) |
Apr 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Buy | M | 5.95 | 2,083 | 12,394 | 3,308 | 1.2 K to 3.3 K (+170.04 %) |
Apr 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Buy | M | 46.00 | 521 | 23,966 | 1,225 | 704 to 1.2 K (+74.01 %) |
Apr 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Buy | M | 27.60 | 417 | 11,509 | 704 | 287 to 704 (+145.30 %) |
Mar 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Option Exercise | M | 5.95 | 383 | 2,279 | 11,884 | |
Mar 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Option Exercise | M | 5.95 | 2,083 | 12,394 | 64,584 | |
Mar 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Option Exercise | M | 46.00 | 521 | 23,966 | 11,465 | |
Mar 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Option Exercise | M | 27.60 | 417 | 11,509 | 4,175 | |
Mar 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 168.09 | 190 | 31,937 | 287 | 477 to 287 (-39.83 %) |
Mar 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Payment of Exercise | F | 174.84 | 179 | 31,296 | 477 | 656 to 477 (-27.29 %) |
Mar 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | D | 174.84 | 14 | 2,448 | 656 | 670 to 656 (-2.09 %) |
Mar 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Buy | M | 5.95 | 383 | 2,279 | 670 | 287 to 670 (+133.45 %) |
Mar 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 175.16 | 12 | 2,102 | 287 | 299 to 287 (-4.01 %) |
Mar 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 173.54 | 186 | 32,278 | 299 | 485 to 299 (-38.35 %) |
Mar 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 172.24 | 203 | 34,964 | 485 | 688 to 485 (-29.51 %) |
Mar 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 171.23 | 314 | 53,767 | 688 | 1 K to 688 (-31.34 %) |
Mar 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 170.26 | 336 | 57,206 | 1,002 | 1.3 K to 1 K (-25.11 %) |
Mar 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 168.89 | 91 | 15,369 | 1,338 | 1.4 K to 1.3 K (-6.37 %) |
Mar 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 167.73 | 167 | 28,011 | 1,429 | 1.6 K to 1.4 K (-10.46 %) |
Mar 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 166.48 | 263 | 43,784 | 1,596 | 1.9 K to 1.6 K (-14.15 %) |
Mar 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 163.53 | 162 | 26,492 | 1,859 | 2 K to 1.9 K (-8.02 %) |
Mar 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 160.82 | 172 | 27,661 | 2,021 | 2.2 K to 2 K (-7.84 %) |
Mar 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 159.02 | 101 | 16,061 | 2,193 | 2.3 K to 2.2 K (-4.40 %) |
Mar 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 157.08 | 160 | 25,133 | 2,294 | 2.5 K to 2.3 K (-6.52 %) |
Mar 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 155.64 | 135 | 21,011 | 2,454 | 2.6 K to 2.5 K (-5.21 %) |
Mar 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 154.00 | 185 | 28,490 | 2,589 | 2.8 K to 2.6 K (-6.67 %) |
Mar 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 153.25 | 312 | 47,812 | 2,774 | 3.1 K to 2.8 K (-10.11 %) |
Mar 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 152.40 | 150 | 22,859 | 3,086 | 3.2 K to 3.1 K (-4.64 %) |
Mar 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 150.31 | 72 | 10,822 | 3,236 | 3.3 K to 3.2 K (-2.18 %) |
Mar 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Buy | M | 5.95 | 2,083 | 12,394 | 3,308 | 1.2 K to 3.3 K (+170.04 %) |
Mar 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Buy | M | 46.00 | 521 | 23,966 | 1,225 | 704 to 1.2 K (+74.01 %) |
Mar 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Buy | M | 27.60 | 417 | 11,509 | 704 | 287 to 704 (+145.30 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Option Exercise | M | 5.95 | 384 | 2,285 | 12,267 | |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Option Exercise | M | 5.95 | 2,084 | 12,400 | 66,667 | |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Option Exercise | M | 46.00 | 521 | 23,966 | 11,986 | |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Option Exercise | M | 27.60 | 417 | 11,509 | 4,592 | |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 324.50 | 194 | 62,953 | 287 | 481 to 287 (-40.33 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Payment of Exercise | F | 290.18 | 182 | 52,813 | 481 | 663 to 481 (-27.45 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | D | 290.18 | 8 | 2,321 | 663 | 671 to 663 (-1.19 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Buy | M | 5.95 | 384 | 2,285 | 671 | 287 to 671 (+133.80 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 298.80 | 25 | 7,470 | 287 | 312 to 287 (-8.01 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 297.82 | 30 | 8,935 | 312 | 342 to 312 (-8.77 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 296.96 | 104 | 30,884 | 342 | 446 to 342 (-23.32 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 296.01 | 238 | 70,451 | 446 | 684 to 446 (-34.80 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 295.05 | 625 | 184,404 | 684 | 1.3 K to 684 (-47.75 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 293.96 | 405 | 119,054 | 1,309 | 1.7 K to 1.3 K (-23.63 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 292.91 | 272 | 79,670 | 1,714 | 2 K to 1.7 K (-13.70 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 291.79 | 117 | 34,139 | 1,986 | 2.1 K to 2 K (-5.56 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 290.86 | 57 | 16,579 | 2,103 | 2.2 K to 2.1 K (-2.64 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 289.45 | 55 | 15,920 | 2,160 | 2.2 K to 2.2 K (-2.48 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 287.03 | 30 | 8,611 | 2,215 | 2.2 K to 2.2 K (-1.34 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 284.82 | 25 | 7,121 | 2,245 | 2.3 K to 2.2 K (-1.10 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 283.50 | 1,020 | 289,171 | 2,270 | 3.3 K to 2.3 K (-31.00 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | S | 282.00 | 19 | 5,358 | 3,290 | 3.3 K to 3.3 K (-0.57 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Buy | M | 5.95 | 2,084 | 12,400 | 3,309 | 1.2 K to 3.3 K (+170.12 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Buy | M | 46.00 | 521 | 23,966 | 1,225 | 704 to 1.2 K (+74.01 %) |
Feb 09 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Buy | M | 27.60 | 417 | 11,509 | 704 | 287 to 704 (+145.30 %) |
Jan 27 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, Chief Commerci ... | Sell | D | 128.60 | 73 | 9,388 | 287 | 360 to 287 (-20.28 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Option Exercise | M | 5.95 | 1,149 | 6,837 | 12,651 | |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Option Exercise | M | 5.95 | 6,249 | 37,182 | 68,751 | |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Option Exercise | M | 46.00 | 2,082 | 95,772 | 12,507 | |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Option Exercise | M | 27.60 | 1,668 | 46,037 | 5,009 | |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Option Exercise | M | 27.00 | 2,214 | 59,778 | 0 | |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Option Exercise | M | 27.00 | 394 | 10,638 | 0 | |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Sell | S | 124.17 | 506 | 62,830 | 287 | 793 to 287 (-63.81 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Payment of Exercise | F | 116.24 | 584 | 67,884 | 793 | 1.4 K to 793 (-42.41 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Sell | D | 116.24 | 59 | 6,858 | 1,377 | 1.4 K to 1.4 K (-4.11 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Buy | M | 5.95 | 1,149 | 6,837 | 1,436 | 287 to 1.4 K (+400.35 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Sell | S | 115.11 | 349 | 40,172 | 287 | 636 to 287 (-54.87 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Sell | S | 114.25 | 1,500 | 171,378 | 636 | 2.1 K to 636 (-70.22 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Sell | S | 113.29 | 3,500 | 396,511 | 2,136 | 5.6 K to 2.1 K (-62.10 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Sell | S | 112.19 | 4,194 | 470,525 | 5,636 | 9.8 K to 5.6 K (-42.67 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Sell | S | 111.19 | 4,164 | 463,003 | 9,830 | 14 K to 9.8 K (-29.76 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Sell | S | 110.25 | 3,700 | 407,934 | 13,994 | 17.7 K to 14 K (-20.91 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Buy | M | 5.95 | 6,249 | 37,182 | 17,694 | 11.4 K to 17.7 K (+54.60 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Buy | M | 46.00 | 2,082 | 95,772 | 11,445 | 9.4 K to 11.4 K (+22.24 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Buy | M | 27.60 | 1,668 | 46,037 | 9,363 | 7.7 K to 9.4 K (+21.68 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Buy | M | 27.00 | 2,214 | 59,778 | 7,695 | 5.5 K to 7.7 K (+40.39 %) |
Jan 07 2021 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Buy | M | 27.00 | 394 | 10,638 | 5,481 | 5.1 K to 5.5 K (+7.75 %) |
Dec 16 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Option Exercise | A | 0.00 | 4,800 | 0 | 4,800 | |
Dec 16 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CMO and CBO | Option Exercise | A | 129.70 | 9,500 | 1,232,150 | 9,500 | |
Oct 01 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 115.08 | 109 | 12,544 | 5,087 | 5.2 K to 5.1 K (-2.10 %) |
Oct 01 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 114.03 | 214 | 24,402 | 5,196 | 5.4 K to 5.2 K (-3.96 %) |
Oct 01 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 112.78 | 58 | 6,541 | 5,410 | 5.5 K to 5.4 K (-1.06 %) |
Oct 01 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 112.03 | 160 | 17,925 | 5,468 | 5.6 K to 5.5 K (-2.84 %) |
Oct 01 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 110.85 | 332 | 36,802 | 5,628 | 6 K to 5.6 K (-5.57 %) |
Oct 01 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 109.59 | 353 | 38,686 | 5,960 | 6.3 K to 6 K (-5.59 %) |
Oct 01 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 108.57 | 945 | 102,601 | 6,313 | 7.3 K to 6.3 K (-13.02 %) |
Oct 01 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 107.60 | 79 | 8,501 | 7,258 | 7.3 K to 7.3 K (-1.08 %) |
Sep 30 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Option Exercise | M | 5.95 | 4,600 | 27,370 | 13,800 | |
Sep 30 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Option Exercise | M | 5.95 | 25,000 | 148,750 | 75,000 | |
Sep 30 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 109.12 | 2,432 | 265,383 | 7,337 | 9.8 K to 7.3 K (-24.90 %) |
Sep 30 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 108.08 | 4,751 | 513,480 | 9,769 | 14.5 K to 9.8 K (-32.72 %) |
Sep 30 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 107.05 | 5,653 | 605,133 | 14,520 | 20.2 K to 14.5 K (-28.02 %) |
Sep 30 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 106.04 | 5,485 | 581,634 | 20,173 | 25.7 K to 20.2 K (-21.38 %) |
Sep 30 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 117.07 | 551 | 64,503 | 25,658 | 26.2 K to 25.7 K (-2.10 %) |
Sep 30 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 116.08 | 951 | 110,389 | 26,210 | 27.2 K to 26.2 K (-3.50 %) |
Sep 30 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 115.23 | 1,003 | 115,577 | 27,160 | 28.2 K to 27.2 K (-3.56 %) |
Sep 30 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 113.81 | 401 | 45,639 | 28,163 | 28.6 K to 28.2 K (-1.40 %) |
Sep 30 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 113.02 | 727 | 82,168 | 28,564 | 29.3 K to 28.6 K (-2.48 %) |
Sep 30 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 111.92 | 216 | 24,175 | 29,291 | 29.5 K to 29.3 K (-0.73 %) |
Sep 30 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 110.97 | 2,343 | 260,012 | 29,506 | 31.8 K to 29.5 K (-7.36 %) |
Sep 30 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 109.98 | 8,133 | 894,458 | 31,849 | 40 K to 31.8 K (-20.34 %) |
Sep 30 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 109.07 | 6,661 | 726,503 | 39,982 | 46.6 K to 40 K (-14.28 %) |
Sep 30 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 108.20 | 3,739 | 404,549 | 46,643 | 50.4 K to 46.6 K (-7.42 %) |
Sep 30 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 107.22 | 276 | 29,593 | 50,383 | 50.7 K to 50.4 K (-0.54 %) |
Sep 30 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Payment of Exercise | F | 111.18 | 2,103 | 233,812 | 50,658 | 52.8 K to 50.7 K (-3.99 %) |
Sep 30 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | D | 111.18 | 247 | 27,461 | 52,761 | 53 K to 52.8 K (-0.47 %) |
Sep 30 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Buy | M | 5.95 | 4,600 | 27,370 | 53,008 | 48.4 K to 53 K (+9.50 %) |
Sep 30 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Buy | M | 5.95 | 25,000 | 148,750 | 48,408 | 23.4 K to 48.4 K (+106.80 %) |
Sep 29 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Option Exercise | M | 0.00 | 3,538 | 0 | 7,076 |